(Q44430771)

2 December 2017

Novel selective and metabolically stable inhibitors of anandamide cellular uptake (English)

1 reference

2 December 2017

0 references

0 references

5

1 reference

2 December 2017

Enrico Morera

4

0 references

Luciano De Petrocellis

series ordinal

3

object named as

Luciano De Petrocellis

1 reference

2 December 2017

Giorgio Ortar

1

1 reference

PubMed ID

12732359

2 December 2017

Alessia Ligresti

series ordinal

2

1 reference

PubMed ID

12732359

2 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

2 December 2017

Biochemical Pharmacology

1 reference

2 December 2017

65

1 reference

2 December 2017

1473-1481

1 reference

2 December 2017

9

1 reference

Pharmacology of cannabinoid CB1 and CB2 receptors.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric Oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Anandamide hydrolysis by human cells in culture and brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Interactions between synthetic vanilloids and the endogenous cannabinoid system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

The anandamide transport inhibitor AM404 activates vanilloid receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Structural determinants for recognition and translocation by the anandamide transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Natural and synthetic endocannabinoids and their structure-activity relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900109-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(03)00109-6

1 reference

2 December 2017

1 reference

PubMed ID

12732359